Fluorobiotech was founded during the global pandemic, in response to the urgent need for accessible and affordable biotechnology solutions. The company commits itself to bridging this gap by pioneering affordable, cutting-edge biotechnology solutions tailored to emerging markets.

Fluorobiotech offers a self-prep technology designed to burst cells open automatically without mechanical disruption or added chemicals. This genetic modification enables rapid, efficient protein release, simplifying the protein extraction process, reducing costs, and improving repeatability for protein production.

Immobazyme is a South African biotechnology spin-out company of Stellenbosch University that utilises precision fermentation to produce high-value active protein ingredients. Their mission is to catalyse the future of global innovation with precision fermentation. By creating the most desirable and accessible recombinant proteins, they aim to enable businesses to perfect their products and unlock the full potential of their process development.

Impulse Biomed is a developer of medical devices dedicated to making healthcare more affordable. One such product is the Easy Squeezy, an asthma pump device that makes it easier for people to activate their inhalers. Another product is ZiBiPen, adrenaline auto-injectors can be customized for any patient, such as the needle length, dose, and more, enabling patients to get an emergency treatment of anaphylaxis.

Hyrax Biosciences is an award-winning genetic software company that takes the complexity out of sequence data analysis for companies around the world. Its automated platform, Exatype, a leading bioinformatics software platform, combines scalable tech and unique algorithms to deliver detailed and accurate genotype reports, without the need for human intervention or the threat of human error.